ClinicalTrialsFinder

Neuromyelitis Optica Spectrum Disorder (NMOSD) Clinical Trials in Wuhan

1 recruitingWuhan, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Neuromyelitis Optica Spectrum Disorder (NMOSD)Multiple Sclerosis (MS)Myasthenia Gravis (MG)+3 more
Tongji Hospital6 enrolled1 locationNCT07526493